Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Auris Medical obtains fast track designation for Keyzilen

July 19, 2016

Strekin begins phase II study of STR-001

April 29, 2016

Boehringer Ingelheim and Kyoto University to investigate new drugs for sensorineural hearing loss

April 5, 2016

Otonomy launches Otiprio in U.S.

March 3, 2016

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Feb. 4, 2016

3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum

Jan. 26, 2016

Sensorion cleared to initiate phase I trial of SENS-218 in U.K.

Jan. 7, 2016

FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement

Dec. 14, 2015

Otonomy begins enrollment in phase III trial of OTO-104 in Meniere's disease

Nov. 20, 2015

Otonomy initiates clinical development of OTO-311 for tinnitus

Nov. 17, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...